The European Centre for Disease Prevention and Control (ECDC) has published its latest Annual Epidemiological Reports shedding light on the state of sexually transmitted infections (STIs) in the European Union/European Economic Area (EU/EEA).
For 2022, 216 508 confirmed cases of chlamydia infection were reported in 27 EU/EEA countries, with a crude notification rate of 88 cases per 100 000 population.
This joint guidance by the ECDC and EMCDDA aims to strengthen the evidence base for developing national strategies for preventing and controlling infections and infectious diseases among people who inject drugs.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 17-23 December 2023 and includes updates on cholera, SARS-CoV-2 variant classification, avian influenza in fur farms, hepatitis A, pertussis, a cluster of extensively drug-resistant Shigella Sonnei among men who have sex with men, and an overview of respiratory virus epidemiology in the EU/EE.
In 2022, the first and second most reported zoonoses in humans were campylobacteriosis and salmonellosis, respectively. The number of cases of campylobacteriosis and salmonellosis remained stable in comparison with 2021.
Lymphogranuloma venereum (LGV) is a systemic sexually transmitted infection (STI) caused by Chlamydia trachomatis serovars L1, L2, or L3. In 2021, 1 124 cases of LGV were reported by 23 EU/EEA Member States.
For 2021, 27 EU/EEA Member States reported 184 542 confirmed cases of chlamydia infection. The crude notification rate was 74 cases per 100 000 population.
In a series of reports released by ECDC, a concerning rise in sexually transmitted infections (STIs) across Europe has been revealed indicating troubling trends and significant public health implications.